Pictet Asset Management (UK)’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | $331M | Sell |
4,802,990
-413,477
| -8% | -$27.6M | 0.36% | 78 |
|
|
2021
Q1 | $337M | Buy |
5,216,467
+991,486
| +23% | +$63.9M | 0.41% | 63 |
|
|
2020
Q4 | $246M | Buy |
4,224,981
+63,431
| +2% | +$3.83M | 0.32% | 91 |
|
|
2020
Q3 | $263M | Buy |
4,161,550
+546,418
| +15% | +$37.9M | 0.41% | 64 |
|
|
2020
Q2 | $278M | Buy |
3,615,132
+352,727
| +11% | +$27M | 0.48% | 47 |
|
|
2020
Q1 | $244M | Sell |
3,262,405
-991,970
| -23% | -$68.5M | 0.52% | 46 |
|
|
2019
Q4 | $276M | Sell |
4,254,375
-300,991
| -7% | -$19.6M | 0.49% | 49 |
|
|
2019
Q3 | $289M | Buy |
4,555,366
+177,211
| +4% | +$11.6M | 0.61% | 36 |
|
|
2019
Q2 | $296M | Buy |
4,378,155
+832,194
| +23% | +$54.7M | 0.64% | 28 |
|
|
2019
Q1 | $231M | Buy |
3,545,961
+299,760
| +9% | +$19.9M | 0.51% | 40 |
|
|
2018
Q4 | $203K | Sell |
3,246,201
-69,725
| -2% | -$4.87M | 0.51% | 41 |
|
|
2018
Q3 | $256M | Sell |
3,315,926
-307,073
| -8% | -$23.2M | 0.54% | 29 |
|
|
2018
Q2 | $257M | Buy |
3,622,999
+20,104
| +0.6% | +$1.42M | 0.61% | 23 |
|
|
2018
Q1 | $272M | Buy |
3,602,895
+8,254
| +0.2% | +$656K | 0.67% | 17 |
|
|
2017
Q4 | $258M | Buy |
3,594,641
+132,609
| +4% | +$10.1M | 0.66% | 23 |
|
|
2017
Q3 | $280M | Buy |
3,462,032
+849,771
| +33% | +$65M | 0.79% | 12 |
|
|
2017
Q2 | $170M | Sell |
2,612,261
-165,528
| -6% | -$11M | 0.52% | 42 |
|
|
2017
Q1 | $189M | Buy |
2,777,789
+163,754
| +6% | +$11.5M | 0.62% | 29 |
|
|
2016
Q4 | $187M | Buy |
2,614,035
+256,140
| +11% | +$19M | 0.7% | 26 |
|
|
2016
Q3 | $187M | Buy |
2,357,895
+234,351
| +11% | +$19M | 0.7% | 27 |
|
|
2016
Q2 | $185M | Buy |
2,123,544
+614,845
| +41% | +$54.6M | 0.72% | 25 |
|
|
2016
Q1 | $132M | Sell |
1,508,699
-41,787
| -3% | -$3.77M | 0.58% | 39 |
|
|
2015
Q4 | $157M | Sell |
1,550,486
-125,303
| -7% | -$13M | 0.66% | 27 |
|
|
2015
Q3 | $165M | Buy |
1,675,789
+61,963
| +4% | +$6.88M | 0.72% | 23 |
|
|
2015
Q2 | $190M | Buy |
1,613,826
+54,636
| +4% | +$5.97M | 0.78% | 19 |
|
|
2015
Q1 | $157M | Buy |
1,559,190
+377,471
| +32% | +$38.3M | 0.65% | 24 |
|
|
2014
Q4 | $111M | Buy |
1,181,719
+181,007
| +18% | +$18.7M | 0.5% | 43 |
|
|
2014
Q3 | $107M | Sell |
1,000,712
-25,200
| -2% | -$2.47M | 0.51% | 44 |
|
|
2014
Q2 | $85.1M | Sell |
1,025,912
-24,212
| -2% | -$1.88M | 0.41% | 61 |
|
|
2014
Q1 | $74.4M | Buy |
1,050,124
+38,012
| +4% | +$2.98M | 0.37% | 72 |
|
|
2013
Q4 | $76.1M | Sell |
1,012,112
-44,700
| -4% | -$3.11M | 0.39% | 68 |
|
|
2013
Q3 | $66.4M | Sell |
1,056,812
-54,600
| -5% | -$3.26M | 0.37% | 76 |
|
|
2013
Q2 | $56.9M | Buy |
+1,111,412
| New | +$57.9M | 0.33% | 82 |
|
Other funds holding GILD
Pictet Asset Management (UK)'s GILD Position: Q2 2021 in Review
Pictet Asset Management (UK) reduced its Gilead Sciences (GILD) stake by 7.9% in Q2 2021, selling an estimated $27.6M and leaving 4,802,990 shares worth $331M. The position accounts for 0.36% of the portfolio, ranked #78.
Pictet Asset Management (UK) first reported a position in GILD in Q2 2013 and has held it in 33 quarters since. The position peaked at $337M in Q1 2021. 1,545 funds tracked by Wall St. Rank hold GILD as of Q2 2021.
- Pictet Asset Management (UK) held 4,802,990 shares of Gilead Sciences worth $331M as of Q2 2021.
- Pictet Asset Management (UK) sold 413,477 Gilead Sciences shares in Q2 2021, an estimated $27.6M.
- Gilead Sciences made up 0.36% of Pictet Asset Management (UK)'s portfolio in Q2 2021, its #78 holding.
- Pictet Asset Management (UK) first reported a position in Gilead Sciences in Q2 2013 and has held it in 33 quarters since.
- Pictet Asset Management (UK)'s Gilead Sciences position peaked at $337M in Q1 2021.
- 1,545 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2021.
Based on Pictet Asset Management (UK)'s 13F filing for Q2 2021, filed 16 Aug 2021.